Test environment running 7.6.3
 

Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions

dc.contributor.authorOlsen, Markus Harboeen
dc.contributor.authorJensen, Aksel Karl Georgen
dc.contributor.authorDankiewicz, Josefen
dc.contributor.authorSkrifvars, Markus B.en
dc.contributor.authorReinikainen, Mattien
dc.contributor.authorTiainen, Marjaanaen
dc.contributor.authorSaxena, Manojen
dc.contributor.authorAneman, Andersen
dc.contributor.authorGluud, Christianen
dc.contributor.authorUllén, Susannen
dc.contributor.authorNielsen, Niklasen
dc.contributor.authorJakobsen, Janus Christianen
dc.date.accessioned2025-03-28T04:22:54Z
dc.date.available2025-03-28T04:22:54Z
dc.date.issued2022en
dc.description.abstractBackground: Randomised clinical trials with a factorial design may assess the effects of multiple interventions in the same population. Factorial trials are carried out under the assumption that the trial interventions have no interactions on outcomes. Here, we present a protocol for a simulation study investigating the consequences of different levels of interactions between the trial interventions on outcomes for the future 2×2×2 factorial designed randomised clinical Sedation, TEmperature, and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial in comatose patients after out-of-hospital cardiac arrest. Methods: By simulating a multisite trial with 50 sites and 3278 participants, and a presumed six-month all-cause mortality of 60% in the control population, we will investigate the validity of the trial results with different levels of interaction effects on the outcome. The primary simulation outcome of the study is the risks of type-1 and type-2 errors in the simulated scenarios, i.e. at what level of interaction is the desired alpha and beta level exceeded. When keeping the overall risk of type-1 errors ≤ 5% and the risk of type-2 errors ≤ 10%, we will quantify the maximum interaction effect we can accept if the planned sample size is increased by 5% to take into account possible interaction between the trial interventions. Secondly, we will assess how interaction effects influence the minimal detectable difference we may confirm or reject to take into account 5% (small interaction effect), 10% (moderate), or 15% (large) positive interactions in simulations with no ‘true’ intervention effect (type-1 errors) and small (5%), moderate (10%), or large negative interactions (15%) in simulations with ‘true’ intervention effects (type-2 errors). Moreover, we will investigate how much the sample size must be increased to account for a small, moderate, or large interaction effects. Discussion: This protocol for a simulation study will inform the design of a 2×2×2 factorial randomised clinical trial of how potential interactions between the assessed interventions might affect conclusions. Protocolising this simulation study is important to ensure valid and unbiased results.en
dc.description.statustrueen
dc.identifier.otherScopus:85140350539en
dc.identifier.otherPubMed:36273179en
dc.identifier.urihttps://dspace-test.anu.edu.au/handle/1885/733743351
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85140350539&partnerID=8YFLogxKen
dc.language.isoEnglishen
dc.rightsPublisher Copyright: © 2022, The Author(s).en
dc.sourceTrialsen
dc.subjectFactorial designen
dc.subjectInteractionsen
dc.subjectProtocolen
dc.subjectRandomised clinical trialen
dc.subjectSimulation studyen
dc.subjectStatistical analysis planen
dc.titleInteractions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusionsen
dc.typeArticleen
local.contributor.affiliationOlsen, Markus Harboe; University of Copenhagenen
local.contributor.affiliationJensen, Aksel Karl Georg; University of Copenhagenen
local.contributor.affiliationDankiewicz, Josef; Lund Universityen
local.contributor.affiliationSkrifvars, Markus B.; Helsinki University Hospitalen
local.contributor.affiliationReinikainen, Matti; University of Eastern Finlanden
local.contributor.affiliationTiainen, Marjaana; Helsinki University Hospitalen
local.contributor.affiliationSaxena, Manoj; University of New South Walesen
local.contributor.affiliationAneman, Anders; South Western Sydney Local Health Districten
local.contributor.affiliationGluud, Christian; University of Copenhagenen
local.contributor.affiliationUllén, Susann; Lund Universityen
local.contributor.affiliationNielsen, Niklas; Lund Universityen
local.contributor.affiliationJakobsen, Janus Christian; University of Copenhagenen
local.identifier.citationvolume23en
local.identifier.doi10.1186/s13063-022-06796-7en
local.identifier.purec3e6470e-17fe-49ee-8959-fc6b3935dd46en
local.type.statusPublisheden

Downloads